2024    2023    2022    2021    2020    2019    2018    2017    2016   

2022

Articles

321 - 

Prevalence of vascular disruption anomalies and association with young maternal age: A EUROCAT study to compare the United Kingdom with other European countries

Joan Morris, Diana Wellesley, Elizabeth Limb, Jorieke Bergman, Agnieszka Kinsner-Ovaskainen et al.

Birth Defects Research, 2022, 114 (20), pp.1417-1426.

DOI : https://doi.org/10.1002/bdr2.2122

Pubmed : 36369770

 

322 - 

Do Not Throw Out the Baby With the Bathwater

Thomas Moumneh, Delphine Douillet, Dominique Savary, Pierre-Marie Roy

Annals of Emergency Medicine, 2022, 79 (1), pp.85-86.

DOI : https://doi.org/10.1016/j.annemergmed.2021.09.429

Pubmed : 34949412

 

323 - 

148 - Co-exposition prénatale au Zika et au plomb et développement à 18 mois [Communication]

G. Muckle, Philippe Quénel, L. Michineau, B. Tressieres, B. Hoen et al.

Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2022, 70, pp.S187-S188.

DOI : https://doi.org/10.1016/j.respe.2022.06.159

 

324 - 

Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

Anne Murarasu, Gaëlle Guettrot-Imbert, Véronique Le Guern, Cécile Yelnik, Viviane Queyrel et al.

The Lancet Rheumatology, 2022, 4 (12), pp.e842-e852.

DOI : https://doi.org/10.1016/S2665-9913(22)00308-3

 

325 - 

BDNF as a potential mediator between childhood BPA exposure and behavioral function in adolescent boys from the INMA-Granada cohort

V. Mustieles, A. Rodríguez-Carrillo, F. Vela-Soria, Shereen Cynthia d'Cruz, Arthur David et al.

Science of the Total Environment, 2022, 803, pp.150014.

DOI : https://doi.org/10.1016/j.scitotenv.2021.150014

Pubmed : 34788942

 

326 - 

The eutopic endometrium proteome in endometriosis reveals candidate markers and molecular mechanisms of physiopathology

Loren Méar, Emmanuelle Com, Khadija Fathallah, Laëtitia Guillot, Régis Lavigne et al.

Diagnostics, 2022, 12 (2), pp.419.

DOI : https://doi.org/10.3390/diagnostics12020419

Pubmed : 35204508

 

327 - 

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

Jean-Marc Naccache, Stéphane Jouneau, Morgane Didier, Raphaël Borie, Marine Cachanado et al.

The Lancet Respiratory Medicine, 2022, 10 (1), pp.26-34.

DOI : https://doi.org/10.1016/S2213-2600(21)00354-4

 

328 - 

Human Testicular Germ Cells, a Reservoir for Zika Virus, Lack Antiviral Response Upon Zika or Poly(I:C) Exposure

Ohiniba Nadège Kuassivi, Hervé Abiven, Anne-Pascale Satie, Matéo Cartron, Dominique Mahé et al.

Frontiers in Immunology, 2022, 13, pp.909341.

DOI : https://doi.org/10.3389/fimmu.2022.909341

Pubmed : 35784373

 

329 - 

Human chlorine gas exposition and its management – an umbrella review on human data

Aboubakari Nambiema, Gabrielle Coyo, Jean-Baptiste Barbe-Richaud, Jeremy Blottiaux, Nicolas Retière-Doré et al.

Critical Reviews in Toxicology, 2022, 52 (1), pp.32-50.

DOI : https://doi.org/10.1080/10408444.2022.2035317

Pubmed : 35275027

 

330 - 

A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole

Florian Naudet, André Gillibert, Barbara Mintzes, Alain Braillon, Lisa Cosgrove et al.

Journal of Clinical Psychiatry, 2022, 83 (5), pp.22lr14503.

DOI : https://doi.org/10.4088/JCP.22lr14503

Pubmed : 35921513